Q9L5C8 (Q9L5C8_ECOLX) Escherichia coli

Beta-lactamase UniProtKBInterProInteractive Modelling

291 aa; Sequence (Fasta) ; 10 identical sequences: Salmonella typhimurium: A0A5X9H1H6; Leclercia adecarboxylata: A0A7D5G030; Klebsiella pneumoniae: A0A6D2MN59; Enterobacter cloacae: Q1AHA7; Klebsiella aerogenes: A4GVL4; Raoultella ornithinolytica: A0A4D6FYS7; Citrobacter amalonaticus: A0A9C7QTD6; Klebsiella sp. WP4-W18-ESBL-05: A0A7I6S1W6; Enterobacter kobei: A0A2J0PCT0; Enterobacter roggenkampii: A0A7U3M0W1

Available Structures

32 Experimental Structures

DescriptionPDB IDOligo-stateRangeLigands
CTX-M-9 class A beta-lactamase apo crystal structure at 0.88 Angstrom resolution
2p74
monomer29-291
2×PO4; 1×K;
Assess
Atomic resolution structure of CTX-M-9 beta-lactamase
1ylj
monomer29-291
1×GLC; 10×SO4;
Assess
CTX-M-9 class A beta-lactamase complexed with compound 16
4de0
monomer29-291
1×0JB;
Assess
X-ray crystallographic structure of CTX-M-9 beta-lactamase complexed with a boronic acid inhibitor …
1ym1
monomer29-291
2×PO4; 1×SM2;
Assess
CTX-M-9 class A beta-lactamase complexed with compound 18
4de1
monomer29-291
1×0J6; 1×DMS;
Assess
CTX-M-9 class A beta-lactamase complexed with compound 1 (GF4)
3g2y
monomer29-291
1×GF4;
Assess
X-ray crystallographic structure of CTX-M-9 S70G
3hre
monomer29-291
2×PO4;
Assess
CTX-M-9 in complex with the broad spectrum inhibitor 3-(2- carboxyvinyl)benzo(b)thiophene-2-boronic…
4len
monomer29-291
1×2GK;
Assess
X-ray crystallographic structure of CTX-M-9 S70G in complex with hydrolyzed benzylpenicillin
3hvf
monomer29-291
1×PNK;
Assess
CTX-M-9 S70G in complex with cefotaxime
3hlw
monomer29-291
2×CE3;
Assess
X-ray crystallographic structure of CTX-M-9 beta-lactamase complexed with nafcinin-like boronic aci…
1yms
monomer29-291
1×NBF;
Assess
CTX-M-14 N106S mutant
6cyk
monomer29-291
Assess
CTX-M-9 class A beta-lactamase complexed with compound 6 (3G3)
3g32
monomer30-291
1×3G3; 2×DMS;
Assess
CTX-M-9 class A beta-lactamase complexed with compound 11 (1CE)
3g34
monomer30-291
1×1CE; 1×PO4; 1×DMS;
Assess
X-Ray Crystal Structure of Ruthenocenyl-7-Aminodesacetoxycephalosporanic Acid Covalent Acyl-Enyzme …
5ujo
monomer30-291
1×K; 1×8CY; 1×LSI;
Assess
CTX-M-9 class A beta-lactamase complexed with compound 2 (GZ2)
3g2z
monomer30-291
1×GZ2; 3×DMS;
Assess
X-ray crystallographic structure of CTX-M-9 S70G in complex with benzylpenicillin
3huo
monomer30-291
4×PNN;
Assess
CTX-M-9 S70G in complex with piperacillin
3q07
monomer30-291
1×WPP; 1×YPP;
Assess
CTX-M-9 S70G in complex with hydrolyzed piperacillin
3q1f
monomer30-291
2×YPP;
Assess
CTX-M-9 class A beta-lactamase complexed with compound 4 (GF1)
3g31
monomer30-291
3×GF1; 1×PO4; 2×DMS;
Assess
X-ray crystallographic structure of CTX-M-9 beta-lactamase covalently linked to cefoxitin
1ymx
monomer30-291
1×1QL;
Assess
CTX-M-9 class A beta-lactamase complexed with compound 3 (G30)
3g30
monomer30-291
3×G30;
Assess
CTX-M-14 N106S/D240G mutant
6cyn
monomer30-290
Assess
CTX-M9 mutant L48A
5kmt
monomer30-290
2×PO4; 3×K;
Assess
CTX-M-9 beta lactamase mutant - T165W
5kmu
monomer31-291
4×PO4; 1×CL; 3×PEG;
Assess
Crystal structure of CTX-M-14 S70G/N106S/D240G beta-lactamase in complex with hydrolyzed cefotaxime
6cyu
monomer30-290
1×CE4;
Assess
CTX-M-9 class A beta-lactamase complexed with compound 11
4dds
monomer32-291
3×0J7;
Assess
CTX-M-9 class A beta-lactamase complexed with compound 10
4ddy
monomer32-291
4×DN6; 2×DMS;
Assess
CTX-M-9 class A beta-lactamase complexed with compound 12
4de2
monomer32-291
2×DN3;
Assess
CTX-M-9 class A beta-lactamase complexed with compound 12 (F13)
3g35
monomer32-291
2×F13;
Assess
CTX-M-9 class A beta-lactamase complexed with compound 4
4de3
monomer32-291
6×DN8; 1×DMS;
Assess
Crystal structure of CTX-M-14 S70G/N106S beta-lactamase in complex with hydrolyzed cefotaxime
6cyq
monomer31-290
1×CE4;
Assess

1 SWISS-MODEL model

TemplateOligo-stateQMEANDisCoRangeLigandsTrg-Tpl Seq id (%)
5kmt.1.Amonomer0.9230-290
2×K;99.65
Assess